What's in a risk factor? "He who strikes the ball". (Q35082709)

6 August 2017

1 reference

title

What's in a risk factor? "He who strikes the ball". (English)

1 reference

6 August 2017

Capron L

1

1 reference

6 August 2017

1 February 2003

1 reference

6 August 2017

Diabetes and Metabolism

1 reference

6 August 2017

29

1 reference

6 August 2017

6-13

1 reference

6 August 2017

1

1 reference

Ischaemic heart disease: epidemiology, risk factors and cause

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Risk factors for acute myocardial infarction in Indians: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Case-control studies: research in reverse

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Cohort studies: marching towards outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

A survey of 246 suggested coronary risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

New evidence for beneficial effects of statins unrelated to lipid lowering

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Hormone therapy and heart disease after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Dietary fat intake and prevention of cardiovascular disease: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970001-0

7 January 2021

10.1016/S1262-3636(07)70001-0

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12629442